Nebivolol - Open Access .click

Results 61 to 70 of about 2,317 (166)

COMPARATIVE EFFICACY OF LONG-TERM ANTIHYPERTENSIVE MONOTHERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AT THE WORK PLACE

Рациональная фармакотерапия в кардиологии, 2016
Aim. To compare effects of 12-month monotherapy with nebivolol, enalapril and indapamide on blood pressure (BP), left ventricular hypertrophy and quality of life in the locomotive engineers and their assistants with stress-associated hypertension at the ...
О. N. Antropova +4 more
doaj +1 more source

EFFICACY AND TOLERABILITY OF NEBIVOLOL COMPARED WITH OTHER ANTIHYPERTENSIVE DRUGS: A META-ANALYSIS

Российский кардиологический журнал, 2011
Aim: Lowering BP to normal levels without quality of life deterioration is the most important means of reducing cardiovascular risk. Recent studies have challenged the position of beta-adrenoreceptor antagonists (beta-blockers) as first-line ...
L. M. Van Bortel, Francesco Fici, Flavio Mascagni +2 more
doaj

Rhabdomyolysis in a patient taking nebivolol

Kidney Research and Clinical Practice, 2016
β Blockers such as propranolol and labetalol are known to induce toxic myopathy because of their partial β2 adrenoceptor agonistic effect. Nebivolol has the highest β1 receptor affinity among β blockers, and it has never been reported to induce ...
Ye Jin Kim +7 more
doaj +1 more source

Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers

Vascular Health and Risk Management, 2008
André C Schmidt1, Burkhard Flick1, Elke Jahn2, Peter Bramlage31Charité – Universitätsmedizin Berlin, Institute for Clinical Pharmacology and Toxikology, Berlin, Germany; 2Berlin-Chemie AG, Clinical Research and Medical ...
André C Schmidt +3 more
doaj

Nebivolol improves eNOS function and nitric oxide bioavailability in endothelial cells from African Americans [PDF]